ArticleESMO open2026

A randomized, placebo-controlled, phase II study of docetaxel and platinum with or without erlotinib in recurrent/metastatic head and neck squamous-cell carcinomas.

W N William et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.